Sciex will promote the Polly multi-omics platform in conjunction with its mass spectrometry instruments and differential ion mobility technologies.
Bruker signed a codevelopment and comarketing agreement with PreOmics for sample prep, and a partnership with Genedata for proteomics software.
Arcis Biotechnology and Andrew Alliance will comarket their respective technologies for automated nucleic acid stabilization and preparation.
The companies will commercialize Predigraft, a data analysis tool that provides early predictions of risk for allograft rejection and transplant loss.
The firm reported that test volumes for its Cologuard colorectal cancer screening test also rose 79 percent year over year.
Under the agreement, the companies will create a workflow integrating NanoString's GeoMx Digital Spatial Profiling instrument with Leica's Bond RX autostainer.
The deal covers genomic test development services including assay and bioinformatics design assistance and revenue cycle management optimization.
The data analysis pipeline will allow users to pre-process raw InDrop single-cell RNA-seq data and use Partek tools to characterize single cells.
Test volume for the firm's Cologuard colorectal cancer screening test rose 49 percent year over year during the quarter.
The companies will comarket Ultivue's UltiMapper assays with Leica's Bond Rx research staining platform for research applications.
23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.
By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.
NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.
In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.